Biotech Firms In China, India, Brazil Thriving; Time For Big Pharma To Step In?
This article was originally published in PharmAsia News
Executive Summary
By addressing local health challenges and leveraging cost-efficiency in research and development, biotech firms in emerging China, India, Brazil and South Africa (BRISA) are growing faster than ever. Global drug makers can benefit in these markets by sharing expertise and forming collaborations with these companies, say health researchers Rahim Razaie and Peter Singer at the Mclaughlin-Rotman Center for Global Health at the University of Toronto